Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1034

2'-fucosyllactose

Intended Use: Intended for use as an ingredient in exempt hypoallergenic infant formula for term infants at a maximum use level of 2.4 g/L infant formula as consumed. Hypoallergenic formula includes both extensively hydrolyzed cow milk protein- and amino acid-based formulas.
Basis: Scientific procedures
Notifier: Glycom A/S
Notifier Address: Kogle Allé 4
2970 Hørsholm
Denmark
GRAS Notice (releasable information): GRN 1034 (2.1 MB)
FDA's Letter: Pending

96  
-
-